CEI12

CEI12 is an angiotensin I‐converting enzyme inhibitor (ACEI) peptide from aαs1‐casein peptide. CEI12 can be used for hypertension research[1].

Product Specifications

CAS Number

[26046-92-4]

UNSPSC

12352209

Target

Angiotensin-converting Enzyme (ACE)

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cardiovascular Disease

Smiles

O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N2[C@@H](CCC2)C(N[C@@H](CC3=CC=CC=C3)C(N4[C@@H](CCC4)C(N[C@@H](CCC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CC5=CC=CC=C5)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC6=CC=CC=C6)N

Molecular Formula

C72H97N13O15

Molecular Weight

1384.62

References & Citations

[1]Gomes C, et al. Current genetic engineering strategies for the production of antihypertensive ACEI peptides. Biotechnol Bioeng. 2020 Aug;117 (8) :2610-2628.